Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

Dyslipidemia is a well-established risk factor for atherosclerotic cardiovascular disease, and while statins remain the cornerstone of therapy, residual risk persists for many patients. The advent of novel lipid-lowering agents—including PCSK9 inhibitors, bempedoic acid, and ANGPTL3 inhibitors—offers potent LDL reduction beyond statin therapy. Additionally, therapies targeting triglyceride-rich lipoproteins and lipoprotein(a) are under active development, aiming to address previously untreatable risk factors.

Recent outcome trials have demonstrated substantial event reduction with these agents, particularly in high-risk populations. Beyond LDL lowering, attention is turning toward pleiotropic effects such as plaque stabilization and inflammation reduction. This track will explore the expanding therapeutic landscape, discuss barriers to access and cost-effectiveness, and examine integration into treatment guidelines. Participants will also gain insights into ongoing clinical trials that could redefine lipid management strategies in the coming decade.

    Related Conference of Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Novel Lipid-Lowering Therapies and Cardiovascular Outcomes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in